Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome

Ann Intern Med. 2020 Apr 7;172(7):509-510. doi: 10.7326/L20-0052.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants
  • Antiphospholipid Syndrome*
  • Factor Xa Inhibitors
  • Humans
  • Rivaroxaban*
  • Vitamin K

Substances

  • Anticoagulants
  • Factor Xa Inhibitors
  • Vitamin K
  • Rivaroxaban